SG11201609593RA - Phase-shifting formulations - Google Patents

Phase-shifting formulations

Info

Publication number
SG11201609593RA
SG11201609593RA SG11201609593RA SG11201609593RA SG11201609593RA SG 11201609593R A SG11201609593R A SG 11201609593RA SG 11201609593R A SG11201609593R A SG 11201609593RA SG 11201609593R A SG11201609593R A SG 11201609593RA SG 11201609593R A SG11201609593R A SG 11201609593RA
Authority
SG
Singapore
Prior art keywords
formulations
shifting
phase
shifting formulations
Prior art date
Application number
SG11201609593RA
Inventor
Howard L Levine
Ziegler Donimique De
Original Assignee
Ultrast Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ultrast Inc filed Critical Ultrast Inc
Publication of SG11201609593RA publication Critical patent/SG11201609593RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Surgical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
SG11201609593RA 2014-05-16 2015-05-15 Phase-shifting formulations SG11201609593RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461994491P 2014-05-16 2014-05-16
PCT/US2015/031012 WO2015175899A1 (en) 2014-05-16 2015-05-15 Phase-shifting formulations

Publications (1)

Publication Number Publication Date
SG11201609593RA true SG11201609593RA (en) 2016-12-29

Family

ID=54480753

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201609593RA SG11201609593RA (en) 2014-05-16 2015-05-15 Phase-shifting formulations

Country Status (6)

Country Link
US (1) US20170080120A1 (en)
EP (1) EP3142718A4 (en)
CN (1) CN106573089A (en)
AU (1) AU2015258997B2 (en)
SG (1) SG11201609593RA (en)
WO (1) WO2015175899A1 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291025A (en) * 1980-04-11 1981-09-22 Laclede Professional Products, Inc. Agar gel topical dressing
SE456346B (en) * 1984-07-23 1988-09-26 Pharmacia Ab GEL TO PREVENT ADHESION BETWEEN BODY TISSUE AND SET FOR ITS PREPARATION
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
US5266326A (en) * 1992-06-30 1993-11-30 Pfizer Hospital Products Group, Inc. In situ modification of alginate
US6551610B2 (en) * 1995-04-13 2003-04-22 Poly-Med, Inc. Multifaceted compositions for post-surgical adhesion prevention
JP2001526246A (en) * 1997-12-23 2001-12-18 アライアンス・ファーマスーティカル・コーポレイション Methods and compositions for drug delivery and / or adhesion prevention
US6730775B1 (en) * 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
CN100467067C (en) * 2002-05-09 2009-03-11 厄尔特拉斯特有限责任公司 Medium for contrast enhancement or convenience for ultrasonic, endoscopic, and other medical examinations
JP2005524711A (en) * 2002-05-09 2005-08-18 ウルトラスト・リミテッド・ライアビリティ・カンパニー Medium useful for contrast enhancement or for ultrasound, endoscopes and other medical examinations
CA2550718C (en) * 2003-12-30 2013-11-05 Genzyme Corporation Cohesive gels from cross-linked hyaluronan and/or hylan, their preparation and use
CA2859573A1 (en) * 2011-12-16 2013-06-20 Tarix Pharmaceuticals Ltd. Angiotensins for treatment of fibrosis

Also Published As

Publication number Publication date
AU2015258997A1 (en) 2017-01-12
EP3142718A1 (en) 2017-03-22
EP3142718A4 (en) 2017-11-29
WO2015175899A1 (en) 2015-11-19
AU2015258997B2 (en) 2019-04-18
CN106573089A (en) 2017-04-19
US20170080120A1 (en) 2017-03-23

Similar Documents

Publication Publication Date Title
GB201520799D0 (en) None
TWD174427S (en) Spatula
GB201413050D0 (en) None
GB201516266D0 (en) None
GB201407934D0 (en) Formulation
GB201516146D0 (en) None
HUE050450T2 (en) Fluoroalkylfluorene derivatives
GB201419261D0 (en) Formulations
GB201419091D0 (en) Formulations
IL248773A0 (en) Naphthyridinedione derivatives
IL248629B (en) Cycloalkyl-linked diheterocycle derivatives
GB201416727D0 (en) Use
GB201416716D0 (en) Use
IL248835B (en) Ceritinib formulation
GB201407384D0 (en) Formulation
IL251362A0 (en) Formulation
GB201511301D0 (en) Formulation
GB201409138D0 (en) None
SG11201609593RA (en) Phase-shifting formulations
GB201604697D0 (en) None
GB201604696D0 (en) None
GB201421960D0 (en) Use
GB201420534D0 (en) Use
GB201420535D0 (en) Use
GB201420365D0 (en) Use